Merete Krogh

1.7k total citations
17 papers, 233 citations indexed

About

Merete Krogh is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Merete Krogh has authored 17 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Merete Krogh's work include Neuroendocrine Tumor Research Advances (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Merete Krogh is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Merete Krogh collaborates with scholars based in Denmark, Sweden and Spain. Merete Krogh's co-authors include Per Pfeiffer, Stine Brændegaard Winther, Camilla Qvortrup, Sören Möller, Karina Gravgaard Thomsen, Mette Yilmaz, Lone Nørgård Pétersen, Laurids Østergaard Poulsen, Peter Nørgaard and Lars Bastholt and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Merete Krogh

16 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merete Krogh Denmark 6 195 70 43 32 31 17 233
Keigo Chida Japan 6 138 0.7× 62 0.9× 57 1.3× 30 0.9× 22 0.7× 18 194
Nieves Martínez Lago Spain 8 121 0.6× 51 0.7× 29 0.7× 40 1.3× 18 0.6× 44 165
Andrés Muñoz Spain 7 178 0.9× 25 0.4× 71 1.7× 25 0.8× 27 0.9× 18 228
José Luis Manzano Mozo Spain 5 155 0.8× 33 0.5× 46 1.1× 23 0.7× 62 2.0× 15 176
Jody Corbelli Italy 8 118 0.6× 47 0.7× 41 1.0× 23 0.7× 21 0.7× 17 181
Qing Chang China 7 239 1.2× 179 2.6× 23 0.5× 55 1.7× 28 0.9× 21 308
Sandipkumar Patel United States 7 190 1.0× 55 0.8× 11 0.3× 24 0.8× 42 1.4× 20 249
Filippo Pagani Italy 10 194 1.0× 148 2.1× 62 1.4× 53 1.7× 21 0.7× 27 284
Huiping Qiang China 9 288 1.5× 194 2.8× 25 0.6× 61 1.9× 30 1.0× 20 362
Els Monsaert Belgium 6 174 0.9× 61 0.9× 24 0.6× 33 1.0× 44 1.4× 17 228

Countries citing papers authored by Merete Krogh

Since Specialization
Citations

This map shows the geographic impact of Merete Krogh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merete Krogh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merete Krogh more than expected).

Fields of papers citing papers by Merete Krogh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merete Krogh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merete Krogh. The network helps show where Merete Krogh may publish in the future.

Co-authorship network of co-authors of Merete Krogh

This figure shows the co-authorship network connecting the top 25 collaborators of Merete Krogh. A scholar is included among the top collaborators of Merete Krogh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merete Krogh. Merete Krogh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Krogh, Merete, Àlex Teulé, Heinz‐Josef Klümpen, et al.. (2024). 1142O Multivariable analysis of streptozotocin plus 5-fluorouracil and everolimus sequences in advanced pancreatic neuroendocrine tumor patients: The SEQTOR trial (GETNE-1206). Annals of Oncology. 35. S750–S750. 1 indexed citations
3.
Perren, Aurel, Oleksii Nikolaienko, Wei Deng, et al.. (2023). The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine Abstracts.
4.
Herp, Jürgen, Jan-Matthias Braun, Manuella Lech Cantuaria, et al.. (2023). Modeling of Electronic Health Records for Time-Variant Event Learning Beyond Bio-Markers—A Case Study in Prostate Cancer. IEEE Access. 11. 50295–50309. 1 indexed citations
5.
6.
Sørbye, Halfdan, Aurel Perren, Inger Marie Bowitz Lothe, et al.. (2021). 1100MO Molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Annals of Oncology. 32. S910–S911. 1 indexed citations
7.
Pfeiffer, Per, Mette Yilmaz, Sören Möller, et al.. (2020). TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial. The Lancet Oncology. 21(3). 412–420. 150 indexed citations
8.
Pfeiffer, Per, Sören Möller, Merete Krogh, et al.. (2019). Bevacizumab improves efficacy of trifluridine/tipiracil (TAS-102) in patients with chemorefractory metastatic colorectal cancer: a Danish randomized trial. Annals of Oncology. 30. iv130–iv131. 3 indexed citations
9.
10.
Winther, Stine Brændegaard, et al.. (2018). S-1 (Teysuno) and gemcitabine in Caucasian patients with unresectable pancreatic adenocarcinoma. Cancer Chemotherapy and Pharmacology. 81(3). 573–578. 6 indexed citations
11.
Mortensen, Michael Bau, et al.. (2016). Trends in upper gastro-intestinal cancer among the elderly in Denmark, 1980–2012. Acta Oncologica. 55(sup1). 23–28. 5 indexed citations
12.
Winther, Stine Brændegaard, Camilla Qvortrup, Lene Weber Vestermark, et al.. (2016). Experience with S-1 in older Caucasian patients with metastatic colorectal cancer (mCRC): Findings from an observational chart review. Acta Oncologica. 55(7). 881–885. 7 indexed citations
13.
14.
Krogh, Merete, Ib Jarle Christensen, Marna G. Bouwhuis, et al.. (2016). Prognostic and predictive value of YKL-40 in stage IIB-III melanoma. Melanoma Research. 26(4). 367–376. 19 indexed citations
15.
Pfeiffer, Per, Mehmet Yılmaz, Lene Bæksgaard, et al.. (2015). 2348 Trastuzumab with triple chemotherapy (DOC-T) in patients with advanced gastro-esophageal cancer. A phase I/II study. European Journal of Cancer. 51. S450–S451. 1 indexed citations
16.
Pfeiffer, Per, et al.. (2013). Single Institution Experience with S-1 (Teysuno) in Danish Patients with Gastro-Intestinal Cancer. Annals of Oncology. 24. iv74–iv74. 2 indexed citations
17.
Krogh, Merete, Ib Jarle Christensen, Marna G. Bouwhuis, et al.. (2010). Prognostic value of serum YKL-40 in stage IIB-III melanoma patients receiving adjuvant interferon therapy.. Journal of Clinical Oncology. 28(15_suppl). 8587–8587. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keigo Chida Breakdown of academic impact, for papers by Nieves Martínez Lago Breakdown of academic impact, for papers by Andrés Muñoz Breakdown of academic impact, for papers by José Luis Manzano Mozo Breakdown of academic impact, for papers by Jody Corbelli Breakdown of academic impact, for papers by Qing Chang Breakdown of academic impact, for papers by Sandipkumar Patel Breakdown of academic impact, for papers by Filippo Pagani Breakdown of academic impact, for papers by Huiping Qiang Breakdown of academic impact, for papers by Els Monsaert
Rankless by CCL
2026